Mu opioid receptor modulation of somatodendritic dopamine overflow: GABAergic and glutamatergic mechanisms
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Mu opioid receptor (MOR) regulation of somatodendritic dopamine neurotransmission in the ventral tegmental area (VTA) was investigated using conventional microdialysis in freely moving rats and mice. Reverse dialysis of the MOR agonist DAMGO (50 and 100 μ m) into the VTA of rats produced a concentration‐dependent increase in dialysate dopamine concentrations. Basal dopamine overflow in the VTA was unaltered in mice lacking the MOR gene. However, basal γ‐aminobutyric acid (GABA) overflow in these animals was significantly increased, whereas glutamate overflow was decreased. Intra‐VTA perfusion of DAMGO into wild‐type (WT) mice increased dopamine overflow. GABA concentrations were decreased, whereas glutamate concentrations in the VTA were unaltered. Consistent with the loss of MOR, no effect of DAMGO was observed in MOR knockout (KO) mice. These data provide the first direct demonstration of tonically active MOR systems in the VTA that regulate basal glutamatergic and GABAergic neurotransmission in this region. We hypothesize that increased GABAergic neurotransmission following constitutive deletion of MOR is due to the elimination of a tonic inhibitory influence of MOR on GABAergic neurons in the VTA, whereas decreased glutamatergic neurotransmission in MOR KO mice is a consequence of intensified GABA tone on glutamatergic neurons and/or terminals. As a consequence, somatodendritic dopamine release is unaltered. Furthermore, MOR KO mice do not exhibit the positive correlation between basal dopamine levels and the glutamate/GABA ratio observed in WT mice. Together, our findings indicate a critical role of VTA MOR in maintaining an intricate balance between excitatory and inhibitory inputs to dopaminergic neurons.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Matthes, H. W. D., Maldonado, R., Simonin, F., Valverde, O., Slowe, S., Kitchen, I., Befort, K., Dierich, A., Le Meur, M., Dollé, P., et al. (1996) · Nature · doi:10.1038/383819a0 · Cited by 1,722 · cited 2×
“The generation of mice lacking MOPr has been described previously (Matthes et al., 1996; Filliol et al., 2000).”
BackgroundOpioids excite dopamine neurons by hyperpolarization of local interneurons
Johnson, S., & North, R. (1992) · The Journal of Neuroscience · doi:10.1523/jneurosci.12-02-00483.1992 · Cited by 1,637
Floresco, S. B., West, A. R., Ash, B., Moore, H., & Grace, A. A. (2003) · Nature Neuroscience · doi:10.1038/nn1103 · Cited by 1,106
Wise, R. A. (2002) · Neuron · doi:10.1016/s0896-6273(02)00965-0 · Cited by 881 · cited 1×
“This dopamine system is implicated in mediating the reinforcing effects of natural rewards and drugs of abuse (Bozarth & Wise, 1986; Schultz, 1997; Wise, 2002).”
BackgroundMice deficient for δ- and μ-opioid receptors exhibit opposing alterations of emotional responses
Filliol, D., Ghozland, S., Chluba, J., Martin, M., Matthes, H. W. D., Simonin, F., Befort, K., Gavériaux-Ruff, C., Dierich, A., LeMeur, M., et al. (2000) · Nature Genetics · doi:10.1038/76061 · Cited by 672
Exploring the opioid system by gene knockout
Kieffer, B. L., & Gavériaux-Ruff, C. (2002) · Progress in Neurobiology · doi:10.1016/s0301-0082(02)00008-4 · Cited by 620 · cited 2×
“In accordance with the involvement of MOR in drug reinforcement, MOR KO mice demonstrate reduced sensitivity to the reinforcing properties of various drugs of abuse including morphine, heroin, alcohol, Δ9-tetrahydrocannabinol, nicotine and cocaine (Kieffer and Gaveriaux-Ruff, 2002).”
BackgroundDevine, D. P., Leone, P., Pocock, D., & Wise, R. A. (1993) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)39324-9 · Cited by 382
Synaptic regulation of mesocorticolimbic dopamine neurons
White, F. J. (1996) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.19.030196.002201 · Cited by 289 · cited 2×
“There is general agreement that the firing activity of dopaminergic neurons is controlled by their intrinsic properties, as well as inhibitory and excitatory inputs from local neurons and from other brain areas (Johnson & North, 1992b; Kalivas, 1993; White, 1996).”
Background
Cited by
Kappa opioid receptors on dopaminergic neurons are necessary for kappa-mediated place aversion
Chefer, V. I., Bäckman, C. M., Gigante, E. D., & Shippenberg, T. S. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.171 · Cited by 122
Self-citationChefer, V., Meis, J., Wang, G., Kuzmin, A., Bakalkin, G., & Shippenberg, T. (2011) · Addiction Biology · doi:10.1111/j.1369-1600.2010.00272.x · Cited by 61
Self-citationLee, M. R., Gallen, C. L., Zhang, X., Hodgkinson, C. A., Goldman, D., Stein, E. A., & Barr, C. S. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024203 · Cited by 27
“There is a well characterized modulation of dopaminergic signaling by the endogenous opioid system [30,31].”
BackgroundBinge eating and psychostimulant addiction
Blanco-Gandia, M. C., Montagud-Romero, S., & Rodríguez-Arias, M. (2021) · World Journal of Psychiatry · doi:10.5498/wjp.v11.i9.517 · Cited by 14
Metadata
- Authors
- Chefer, V. I., Denoroy, L., Zapata, A., & Shippenberg, T. S.
- Venue
- European Journal of Neuroscience
- Publisher
- Wiley
- Published
- 2009-07
- Volume
- 30
- Issue
- 2
- Pages
- 272-278
- ISSN
- 0953-816X (ISSN-L)
- 1460-9568
- OpenAlex
- W1999907612
- Cited by
- 57
- References
- 8
- FWCI
- 2.13
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Mu opioid receptor modulation of somatodendritic dopamine overflow: GABAergic and glutamatergic mechanisms. https://app.cochat.ai/papers/10.1111/j.1460-9568.2009.06827.x
- The paper
- Chefer, V. I., Denoroy, L., Zapata, A., & Shippenberg, T. S. (2009). Mu opioid receptor modulation of somatodendritic dopamine overflow: GABAergic and glutamatergic mechanisms. European Journal of Neuroscience. https://doi.org/10.1111/j.1460-9568.2009.06827.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.